Cargando…
De Novo Pyrimidine Biosynthesis Connects Cell Integrity to Amphotericin B Susceptibility in Cryptococcus neoformans
The use of amphotericin B (AmB) in conjunction with 5-fluorocytosine (5-FC) is known to be the optimal therapy for treating cryptococcosis, but the mechanism by which 5-FC synergizes with AmB is unknown. In this study, we generated a Cryptococcus neoformans ura1Δ mutant lacking dihydroorotate dehydr...
Autores principales: | Banerjee, Dithi, Umland, Timothy C., Panepinto, John C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112334/ https://www.ncbi.nlm.nih.gov/pubmed/27904878 http://dx.doi.org/10.1128/mSphere.00191-16 |
Ejemplares similares
-
Correction for Banerjee et al., “De Novo Pyrimidine Biosynthesis Connects Cell Integrity to Amphotericin B Susceptibility in Cryptococcus neoformans”
por: Banerjee, Dithi, et al.
Publicado: (2023) -
Inhibition of Nucleotide Biosynthesis Potentiates the Antifungal Activity of Amphotericin B
por: Banerjee, Dithi, et al.
Publicado: (2014) -
Antiphagocytic protein 1 increases the susceptibility of Cryptococcus neoformans to amphotericin B and fluconazole
por: Ghaffar, Muhammad, et al.
Publicado: (2019) -
Tools for Assessing Translation in Cryptococcus neoformans
por: Knowles, Corey M., et al.
Publicado: (2021) -
Effects of environmental factors on sensitivity of Cryptococcus neoformans to fluconazole and amphotericin B
por: Carlson, Tyler, et al.
Publicado: (2021)